Central Garden & Pet Company Stock Predictions

Buy GP7

*Your capital is at risk

37.80€

+0.400 (+1.07%)

At Close: Jan 30, 2023

Currently predicting for Thu, 2 Jul 2026

GP7.F Live board

Community Bull/Bear

Target Next close

Join the GP7.F prediction battle

Create a free account to see the full board, submit your call, compare with other predictors, and build a public record.

Create free account Log in

GP7.F Prediction Chart

Unlock the prediction chart

Registered users can inspect target prices, community averages, and how calls develop across recent sessions.

Create free account Log in

Forecast Desk

3-Month Forecasts For GP7.F

Forecasts map a 66-session price path from approved predictors. Log in or create a free account to view forecasts and request one for this ticker.

Create free account Log in to view forecasts

GP7.F Predictions History

Predictor	Target Session	Target Price	Accuracy
Community predictor	Next session	EUR target	Record locked
Ranked predictor	Previous session	Bullish/Bearish	Score locked

See the prediction record

Create free account Log in

Forecast Desk

Request A 3-Month Forecast

Price path
Approved predictor
3-month horizon

Create Free Account Log In To View Forecasts

ABOUT CENTRAL GARDEN & PET COMPANY

Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. The company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell lymphoma; Phase I clinical trial for the treatment of acute myeloid leukemia (AML) and advanced myelodysplastic syndrome (MDS); Phase 1b trial to test the combination of ALRN-6924 and cytarabine,...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
OSIS $218.29	0.188%	Jun 26
IIIV $20.09	6.32%	Jun 25
JLL $299.78	3.39%	Jun 24
NMRK $15.02	0.599%	Jun 24
X XMAX $8.34	8.99%	Jun 24

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by